Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Other Non-Current Assets (2021 - 2025)

Historic Other Non-Current Assets for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to $34.6 million.

  • Roivant Sciences' Other Non-Current Assets rose 201.89% to $34.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $34.6 million, marking a year-over-year increase of 201.89%. This contributed to the annual value of $32.9 million for FY2025, which is 7897.23% down from last year.
  • Latest data reveals that Roivant Sciences reported Other Non-Current Assets of $34.6 million as of Q4 2025, which was up 201.89% from $27.8 million recorded in Q3 2025.
  • Over the past 5 years, Roivant Sciences' Other Non-Current Assets peaked at $320.2 million during Q3 2024, and registered a low of $11.9 million during Q3 2022.
  • Over the past 5 years, Roivant Sciences' median Other Non-Current Assets value was $33.4 million (recorded in 2024), while the average stood at $55.8 million.
  • In the last 5 years, Roivant Sciences' Other Non-Current Assets skyrocketed by 54310.19% in 2024 and then plummeted by 9130.84% in 2025.
  • Over the past 5 years, Roivant Sciences' Other Non-Current Assets (Quarter) stood at $20.9 million in 2021, then skyrocketed by 121.43% to $46.2 million in 2022, then grew by 1.35% to $46.8 million in 2023, then dropped by 27.68% to $33.9 million in 2024, then grew by 2.02% to $34.6 million in 2025.
  • Its last three reported values are $34.6 million in Q4 2025, $27.8 million for Q3 2025, and $31.1 million during Q2 2025.